Molecular Mechanisms of Adverse Metabolic Drug Effects in Children and Adolescents (R01)

The summary for the Molecular Mechanisms of Adverse Metabolic Drug Effects in Children and Adolescents (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Molecular Mechanisms of Adverse Metabolic Drug Effects in Children and Adolescents (R01)
	CFDA Number:	93.865
	CFDA Description:	Child Health and Human Development Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-HD-10-010
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Aug 30, 2010
	Creation Date:	Aug 30, 2010
	Original Closing Date for Applications:	Nov 30, 2010
	Current Closing Date for Applications:	Nov 30, 2010
	Archive Date:	Dec 31, 2010
	Expected Number of Awards:	5
	Estimated Total Program Funding:	$2,000,000
	Federal Grant Award Ceiling:	$250,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: Purpose. The Eunice Kennedy Shriver National Institute of Child Health and Human Development invite multidisciplinary investigator-initiated grant applications to identify and elucidate molecular mechanisms of adverse metabolic effects of drugs used in children and adolescents. Multidisciplinary collaborations between basic and physician scientists are encouraged. Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Funds Available and Anticipated Number of Awards. NICHD intends to commit $2.0 million (total costs) in FY 2011 to support this FOA.Budgets up to $250,000 in direct costs per year and time periods up to five years may be requested.The anticipated number of awards is five. Budget and Project Period. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will vary.Although the financial plans of the IC(s) provide support for this initiative, awards pursuant to this funding opportunity are contingent upon the availability of funds.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-hd-10-010.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]; • Rehabilitation Research Career Development Programs (K12); • Pediatric Scientist Development Program (PSDP) [K12]; • Translational Research in Pediatric and Obstetric Pharmacology (R21); • Translational Research in Pediatric and Obstetric Pharmacology (R01); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Stud...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Preclinical Stud...; • REPRODUCTIVE GENETICS AND EPIGENETICS; • DEVELOPMENTAL MECHANISMS OF HUMAN STRUCTURAL BIRTH DEFECTS; • ENDOMETRIAL CELL FUNCTION